Investors back Shire takeover

Japanese drugs firm Takeda has won shareholder approval for its £46 billion acquisition of Shire, paving the way for the deal to create one of the biggest pharmaceutical firms in the world.

Takeda said it won support from at least 88 per cent of its shareholders at an extraordinary general meeting in Osaka. Shire investors also overwhelmingly gave the deal the thumbs up.